The purpose of this study is to determine if a 5-day regimen of favipiravir reduces the time to alleviation of influenza symptoms, resolution of fever, and viral shedding, in subjects with uncomplicated influenza compared to no treatment (e.g. placebo).
The purpose of this study is to determine if favipiravir is effective in reducing the time to resolution of influenza symptoms.